View Older Stories View More Recent Stories

Dec 17, 2025 04:31AM Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Dec 16, 2025 11:04AM Nektar Therapeutics (NKTR) PT Raised to $115 at Oppenheimer
Dec 16, 2025 07:30AM Nektar reports mixed phase 2b results for alopecia areata drug
Dec 16, 2025 07:25AM Nektar Therapeutics (NKTR) Halted, News Pending
Nov 24, 2025 05:35AM Nektar Therapeutics (NKTR) PT Raised to $121 at Jefferies
Nov 12, 2025 04:34PM Nektar Therapeutics enters $110 million equity distribution agreement
Nov 10, 2025 03:05AM Oppenheimer Reiterates Outperform Rating on Nektar Therapeutics (NKTR)
Nov 6, 2025 05:15PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 185c
Oct 24, 2025 09:52AM Nektar Therapeutics (NKTR) on Watch Following M&A Chatter
Oct 17, 2025 02:05PM Nektar Therapeutics (NKTR) PT Raised to $105 at B.Riley
Oct 17, 2025 01:32PM Nektar Therapeutics (NKTR) Strength Attributed to Rumor
Sep 18, 2025 03:48PM Nektar Therapeutics (NKTR) PT Raised to $99 at Jefferies
Sep 18, 2025 08:46AM Nektar presents positive Phase 2b atopic dermatitis trial results
Sep 15, 2025 08:32AM Piper Sandler on Nektar Therapeutics (NKTR): 'A Perfect Opportunity to Own NKTR Ahead of Additional AD Data'
Sep 4, 2025 03:39PM Analysts postive on Nektar opportunity after Sanofi data
Aug 7, 2025 04:29PM Nektar Therapeutics (NKTR) Misses Q2 EPS by 258c
Jul 29, 2025 09:01AM Nektar receives FDA fast track for alopecia areata treatment
Jul 1, 2025 07:18AM Nektar Therapeutics (NKTR) Prices 4.26M Share Offering at $23.50/sh
Jun 30, 2025 04:03PM Nektar Therapeutics (NKTR) Announces Proposed Public Offering
Jun 25, 2025 03:20PM Nektar Therapeutics (NKTR) call put ratio 1 call to 1 put on 15K contracts as share price up 24%
Jun 25, 2025 06:39AM Nektar Therapeutics (NKTR) PT Raised to $120 at H.C. Wainwright
Jun 25, 2025 04:56AM Increasing unusual option volume: NKTR RGLS PAGS ASTL NTS HUYA PAYX EWY
Jun 24, 2025 03:41PM Nektar Therapeutics (NKTR) PT Raised to $69 at Jefferies, 'data update gives us further confidence in Rezpeg's potential'
Jun 24, 2025 01:11PM Nektar Therapeutics (NKTR) PT Raised to $100 at BTIG, 'We see NKTR as a "pound the table BUY"'
Jun 24, 2025 10:45AM Increasing unusual option volume: NKTR PAGS GXO SFIX HUYA NTS RZLV MAIN COTY
Jun 24, 2025 07:40AM Nektar Therapeutics (NKTR) to Resume Trading at 8 am
Jun 24, 2025 07:31AM Nektar Therapeutics (NKTR): REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe AD
Jun 24, 2025 07:00AM Nektar Therapeutics (NKTR) Halted, News Pending
Jun 23, 2025 04:31PM Nektar Therapeutics (NKTR) to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June
May 12, 2025 07:03AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
May 9, 2025 05:30AM BTIG Reiterates Buy Rating on Nektar Therapeutics (NKTR)
May 8, 2025 04:43PM Nektar Therapeutics (NKTR) Misses Q1 EPS by 8c
Apr 11, 2025 05:09AM Jefferies Upgrades Nektar Therapeutics (NKTR) to Buy
Mar 28, 2025 04:24PM Nektar Therapeutics (NKTR) Files $300M Mixed Shelf
Mar 14, 2025 01:55AM Oppenheimer Upgrades Nektar Therapeutics (NKTR) to Outperform
Mar 13, 2025 04:46AM BTIG Reiterates Neutral Rating on Nektar Therapeutics (NKTR)
Mar 13, 2025 04:34AM Nektar Therapeutics (NKTR) PT Lowered to $1 at Jefferies
Mar 12, 2025 04:17PM Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c
Feb 26, 2025 07:01AM Nektar Therapeutics (NKTR) Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin
Feb 25, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Feb 24, 2025 11:29PM Piper Sandler Reiterates Overweight Rating on Nektar Therapeutics (NKTR)
Feb 24, 2025 07:00AM Nektar Therapeutics (NKTR) Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus
Feb 10, 2025 07:01AM Nektar Therapeutics (NKTR) Receives Fast Track Designation for Rezpegaldesleukin
Jan 10, 2025 07:03AM Nektar Therapeutics (NKTR) competes target enrollment in its REZOLVE-AD Phase 2b study
Jan 7, 2025 11:35PM B.Riley Starts Nektar Therapeutics (NKTR) at Buy
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Dec 10, 2024 06:36AM H.C. Wainwright Starts Nektar Therapeutics (NKTR) at Buy
Nov 7, 2024 04:32PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 2c
Nov 7, 2024 10:16AM Nektar Therapeutics (NKTR) and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255
Nov 4, 2024 08:30AM Nektar Therapeutics (NKTR) to Sell Commercial PEGylation Reagent Manufacturing Business in Alabama
View More Recent Stories View Older Stories